Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma × Ipilimumab × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 55 Prostatic Neoplasms 32 Kidney Neoplasms 17 Carcinoma, Transitional Cell 15 Melanoma 14 Urinary Bladder Neoplasms 13 Carcinoma, Non-Small-Cell Lung 11 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Clear-cell metastatic renal cell carcinoma 8 Carcinoma, Hepatocellular 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasms 7 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Lung Neoplasms 5 Urogenital Neoplasms 4 Small Cell Lung Carcinoma 4 Endometrial Neoplasms 4 Carcinoma, Merkel Cell 4 Urethral Neoplasms 3 Penile Neoplasms 3 Neuroblastoma 3 Liver Neoplasms 3 Brain Neoplasms 3 Wilms Tumor 2 Ureteral Neoplasms 2

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡